Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.28-2.25PUBT·1 day ago, 04:02 AM01061+1.55%
Essex Bio-Tech files HKEX next-day return disclosing share buyback at HKD 2.3PUBT·Aug 21 at 04:47 AM01061+1.55%
Essex Bio-Tech files HKEX next-day return on share buyback at HKD 2.3PUBT·Aug 19 at 03:48 AM01061+1.55%
Grand Pharma's FDA Nod and Sihuan's Aesthetics Pivot Highlight HK Market ShiftsGlobal Report·Aug 11 at 05:13 AM02695-0.40%03288+0.87%
Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.37PUBT·Aug 7 at 03:52 AM01061+1.55%
Essex Bio-Technology Reports Profit Decline but Strong Balance Sheet in First-Half 2026Tip Ranks·Aug 5 at 06:39 AM01061+1.55%
Essex Bio-Technology Declares Interim Dividend for First Half of 2026Tip Ranks·Aug 5 at 06:39 AM01061+1.55%
Essex Bio-Technology FY26 H1 profit drops 32.2% to HK$ 110.72 million; revenue falls 10.5% to HK$ 784.69 millionPUBT·Aug 5 at 06:24 AM01061+1.55%
Essex Bio-Tech schedules board meeting to review interim results, consider dividendPUBT·Jul 24 at 04:00 AM01061+1.55%
Essex Bio-Tech expects H1 revenue down about 10%, profit down about 30% on China VAT hikePUBT·Jul 17 at 06:04 AM01061+1.55%
The Island of Misfit Stocks: From Elon's Giga Press to Real Estate DefaultsGlobal Report·Jul 17 at 04:12 AM02877-1.19%016850.00%
Hong Kong's Schizophrenic Market: From Surgical Robots to MSGGlobal Report·Jul 9 at 09:02 PM017120.00%01581-1.64%
HKEX Mid-Year Divergence: CIDI's Revenue Surge and Shifting Capital AllocationGlobal Report·Jul 9 at 05:02 AM01581-1.64%02865+1.27%
Hong Kong's Strange New Reality: Why Broad Market Narratives Are DeadGlobal Report·Jul 8 at 10:31 PM01061+1.55%03708+8.52%
Essex Bio-Tech files HKEX next-day disclosure return on share buyback at HKD 2.61 high, HKD 2.5 lowPUBT·Jul 2 at 04:29 AM01061+1.55%
